© 2022 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Latest Conference Articles
Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times Europe® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community
Paediatric eyes repair better with scleral buckling, adults need vitrectomy only for giant retinal tear-related detachments
July 21st 2022, 7:18am
At ASRS 2022, Dr Sally Ong presented a talk entitled, “Vitrectomy vs Vitrectomy With Scleral Buckling in the Treatment of Giant Retinal Tear Related Retinal Detachments: International Multicentre Study.” Here she shares the biggest takeaways.
ASRS 2022 in review: New data on DMO, AMD presented at this year's meeting
July 19th 2022, 7:18am
The American Society of Retina Specialists held its 40th Annual Meeting in New York, New York, United States, from 13-16 July, 2022. While data was presented for all topics in retina, new revelations in age-related macular degeneration, diabetic retinopathy, and diabetic macular oedema dominated the conversation.
ASRS recap: Presentations from 16 July
July 16th 2022, 6:12pm
KALAHARI study update; novel surgical approaches for progressive retinal detachments; and a new risk is identified for CST fluctuations.
ASRS recap: 15 July presentations in review
July 15th 2022, 7:00pm
Metformin may provide AMD protection; DAVIO presents positive 12-month results; TOWER study reveals new imaging index for AMD.
ASRS recap: What was presented on 14 July
July 14th 2022, 8:30am
Topics spanned from faricimab in nAMD and DME; pediatric retinal detachment surgery; and the relationship between outer retinal integrity and subretinal fluid.
ASRS 2022: Retina revelations in NYC
July 7th 2022, 6:24pm
The 40th annual Scientific Meeting of the American Society of Retina Specialists is scheduled for July 13-16, 2022, in New York City, New York, United States.
Ora Europe executive outlines pathway for clinical trials
June 20th 2022, 7:32am
Dr Sally Tucker of Ora Europe walks through the clinical trial pathway, describing how Ora addresses complexities to make the path as efficient as possible.
Phase 1 trial finds at-home subcutaneous injection option safe, effective for the treatment of wet AMD, DMO
June 14th 2022, 7:38am
Jeff Cleland, PhD, CEO of Ashvattha, discusses safety data for an at-home subcutaneous anti-VEGF injection option in development for the treatment of wet AMD and DMO.
OC-01 (varenicline solution) investigated as possible treatment for dry eye symptoms, signs
June 12th 2022, 7:32am
Takeaway: there doesn't seem to be a specific dry eye phenotype that does better or worse.
Cell therapy shows promise for patients with dry AMD, geographic atrophy
June 11th 2022, 7:47am
The OpRegen trial is a cell therapy trial, looking to explore potential safety and efficacy for patients with advanced dry age-related macular degeneration (AMD).